A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

NCT02733068 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12000

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papilloma Virus Infection Type 16
Human Papilloma Virus Infection Type 18
Cervical Intraepithelial Neoplasia

Interventions

BIOLOGICAL: HPV-16/18 vaccine
BIOLOGICAL: HPV-16/18 placebo

Sponsor

Shanghai Zerun Biotechnology Co.,Ltd

Collaborators

[object Object]